Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Urologic Neoplasms × Metastasectomy × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2 Urologic Neoplasms 1 Colonic Neoplasms 1

Interventions

daratumumab 1 Nephrectomy 1 Metastasectomy 1 Fatty Acids, Omega-3 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡